Ethical challenges of HIV clinical trials in developing countries.
D000163:Acquired Immunodeficiency Syndrome; D000533:Altruism; D026686:Beneficence; D000529:Complementary Therapies; D016265:Conflict of Interest; D035061:Control Groups; D003906:Developing Countries; D004345:Drug Industry; D004467:Economics; D026724:Ethical Review; D004989:Ethics; D005610:Freedom; D017408:Guidelines as Topic; D006679:HIV Seropositivity; D006805:Human Experimentation; D006806:Human Rights; D006801:Humans; D007231:Infant, Newborn; D007391:International Cooperation; D038622:Internationality; D009316:National Institutes of Health (U.S.); D026684:Personal Autonomy; D004364:Pharmaceutical Preparations; D010919:Placebos; D011247:Pregnancy; D037841:Pregnant People; D011315:Preventive Medicine; D011640:Public Policy; D012015:Reference Standards; D012106:Research; D012107:Research Design; D012108:Research Personnel; D035842:Research Subjects; D012935:Social Justice; D036302:Therapeutic Human Experimentation; D014481:United States; D015215:Zidovudine
Biomedical and Behavioral Research; Council for International Organizations of Medical Sciences; Declaration of Helsinki; Health Care and Public Health; National Institutes of Health